Guideline panels
Thyroid cancer
Chairs
Hanneke M. van Santen, Wilhelmina Children’s Hospital, UMC Utrecht, Utrecht, The Netherlands and Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
Paul C. Nathan, Hospital for Sick Children, Toronto, Canada
Coordinator
Sarah C. Clement, Emma Children’s Hospital/Academic Medical Center, Amsterdam, the Netherlands
Advisors
Leontien C.M. Kremer, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands and Emma Children’s Hospital, Amsterdam UMC, University of Amsterdam, the Netherlands
Melissa M. Hudson, St. Jude Children’s Research Hospital, Memphis, United States
Roderick Skinner, Great North Children’s Hospital and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK
WG leaders
Melanie Goldfarb, Keck School of Medicine, University of Southern California, Los Angeles, United States
Robin P. Peeters, Erasmus Medical Center, Rotterdam, the Netherlands
Jill Simmons, Vanderbilt University School of Medicine, Nashville, United States
Frederik A. Verburg, RWTH Aachen University Hospital, Aachen, Germany
WG members
Erik Alexander, Women’s Hospital, Boston; Dana Farber Cancer Institute, Boston, United States
Edit Bardi, Kepler Universitätsklinikum, Linz, Austria and Semmelweis University, Budapest, Hungary
Enrico Brignardello, Città della Salute e della Scienza di Torino, Transition Unit for Childhood Cancer Survivors, Turin, Italy
Louis S. Constine, University of Rochester Medical Center, Rochester, United States
Valentina Drozd, Belarusian Medical Academy for Postgraduate Education, Minsk, Belarus
Francesco Felicetti, Città della Salute e della Scienza di Torino, Transition Unit for Childhood Cancer Survivors, Turin, Italy
Eva Frey, St. Anna Children’s Hospital, Medical University Vienna, Vienna, Austria
Alexander Heinzel, RWTH Aachen University Hospital, Aachen, Germany
Stephen Huang, Children’s Hospital Boston, Boston, Massachusetts, United States
Thera P. Links, University Medical Center Groningen, Groningen, the Netherlands
Kerstin Lorenz, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany
Sebastian Neggers, Sophia Children’s Hospital/Erasmus Medical Center, Rotterdam, the Netherlands and Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
Els J.M. Nieveen-van Dijkum, Academic Medical Center, Amsterdam, the Netherlands
Scott A. Rivkees, Yale University School of Medicine, New Haven, United States
Cécile M. Ronckers, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands and Institute for Biostatistics and Registry Research, Brandenburg Medical School, Neuruppin, Germany
Rick R. van Rijn, Academic Medical Center, Amsterdam, the Netherlands
Arthur B. Schneider, University of Illinois, Chicago, United States
Marry M. van den Heuvel-Eibrink, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
Jonathan Wasserman, Hospital for Sick Children/University of Toronto, Toronto, Canada
Catherine A. Welch-Dinauer, Walter Reed Army Medical Center, Washington, United States
Tung Wynn, Shands Hospital, University of Florida, Gainesville, United States